Literature DB >> 20609788

In-parallel artificial lung attachment at high flows in normal and pulmonary hypertension models.

Begum Akay1, Junewai L Reoma, Daniele Camboni, Joshua R Pohlmann, John M Albert, Ayushi Kawatra, Ayanna D Gouch, Robert H Bartlett, Keith E Cook.   

Abstract

BACKGROUND: End-stage lung disease patients who require a thoracic artificial lung (TAL) must be extubated and rehabilitated prior to lung transplantation. The purpose of this study is to evaluate hemodynamics and TAL function under simulated rest and exercise conditions in normal and pulmonary hypertension sheep models.
METHODS: The TAL, the MC3 Biolung (MC3, Inc, Ann Arbor, MI), was attached between the pulmonary artery and left atrium in nine normal sheep and eight sheep with chronic pulmonary hypertension. An adjustable band was placed around the distal pulmonary artery to control the percentage of cardiac output (CO) diverted to the TAL. Pulmonary system hemodynamics and TAL function were assessed at baseline (no flow to the TAL) and with approximately 60%, 75%, and 90% of CO diverted to the TAL. Intravenous dobutamine (0, 2, and 5 mcg . kg(-1). min(-1)) was used to simulate rest and exercise conditions.
RESULTS: At 0 and 2 mcg . kg(-1). min(-1), CO did not change significantly with flow diversion to the TAL for both models. At 5 mcg . kg(-1). min(-1), CO decreased with increasing TAL flow up to 28% +/- 5% in normal sheep and 23% +/- 5% in pulmonary hypertension sheep at 90% flow diversion to the artificial lung. In normal sheep, the pulmonary system zeroth harmonic impedance modulus, Z(0), increased with increasing flow diversion. In hypertensive sheep, Z(0) decreased at 60% and 75% flow diversion and returned to baseline levels at 90%. The TAL outlet blood oxygen saturation was 95% or greater under all conditions.
CONCLUSIONS: Pulmonary artery to left atrial TAL use will not decrease CO during rest or mild exercise but may not allow more vigorous exercise. Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609788      PMCID: PMC4332709          DOI: 10.1016/j.athoracsur.2010.03.085

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Hemodynamic effects of attachment modes and device design of a thoracic artificial lung.

Authors:  F Boschetti; C E Perlman; K E Cook; L F Mockros
Journal:  ASAIO J       Date:  2000 Jan-Feb       Impact factor: 2.872

2.  Hemodynamic and gas transfer properties of a compliant thoracic artificial lung.

Authors:  Keith E Cook; Carrie E Perlman; Ralf Seipelt; Carl L Backer; Constantine Mavroudis; Lyle F Mockrost
Journal:  ASAIO J       Date:  2005 Jul-Aug       Impact factor: 2.872

3.  In vivo hemodynamic responses to thoracic artificial lung attachment.

Authors:  Carrie E Perlman; Keith E Cook; J Ralf Seipelt; J Constantine Mavroudis; J Carl L Backer; Lyle F Mockros
Journal:  ASAIO J       Date:  2005 Jul-Aug       Impact factor: 2.872

4.  Thirty-day in-parallel artificial lung testing in sheep.

Authors:  Hitoshi Sato; Candice M Hall; Nathan G Lafayette; Joshua R Pohlmann; Niru Padiyar; John M Toomasian; Jonathan W Haft; Keith E Cook
Journal:  Ann Thorac Surg       Date:  2007-10       Impact factor: 4.330

5.  Cardiac output during high afterload artificial lung attachment.

Authors:  Jeongho Kim; Hitoshi Sato; Grant W Griffith; Keith E Cook
Journal:  ASAIO J       Date:  2009 Jan-Feb       Impact factor: 2.872

6.  The relationship between pulmonary system impedance and right ventricular function in normal sheep.

Authors:  Alexander S Kuo; Hitoshi Sato; Junewai L Reoma; Keith E Cook
Journal:  Cardiovasc Eng       Date:  2009-12

7.  Importance of metabolic function of the natural lung evaluated by prolonged exclusion of the pulmonary circulation.

Authors:  K Eya; E Tatsumi; Y Taenaka; Y Takewa; K Toda; Y Wakisaka; T Nakatani; T Masuzawa; Y Baba; K Miyazaki; T Nishimura; T Ohno; J M Ahn; H Akagi; H Takano
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

8.  Immediate cardiac allograft failure. ECMO versus total artificial heart support.

Authors:  R M Adamson; W P Dembitsky; P O Daily; R Moreno-Cabral; J Copeland; R Smith
Journal:  ASAIO J       Date:  1996 Jul-Aug       Impact factor: 2.872

9.  Pulmonary capillary endothelial metabolic function in chronic thromboembolic pulmonary hypertension.

Authors:  S E Orfanos; A M Hirsch; M Giovinazzo; A Armaganidis; J D Catravas; D Langleben
Journal:  J Thromb Haemost       Date:  2008-06-04       Impact factor: 5.824

10.  Mechanical determinants of myocardial oxygen consumption in conscious dogs.

Authors:  J R Elbeery; J C Lucke; M P Feneley; G W Maier; C H Owen; R E Lilly; M A Savitt; M S Hickey; S A Gall; J W Davis
Journal:  Am J Physiol       Date:  1995-08
  10 in total
  9 in total

1.  Thoracic artificial lung impedance studies using computational fluid dynamics and in vitro models.

Authors:  Rebecca E Schewe; Khalil M Khanafer; Ryan A Orizondo; Keith E Cook
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

2.  Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung.

Authors:  David J Skoog; Joshua R Pohlmann; David S Demos; Christopher N Scipione; Amit Iyengar; Rebecca E Schewe; Ahmed B Suhaib; Kelly L Koch; Keith E Cook
Journal:  ASAIO J       Date:  2017 Sep/Oct       Impact factor: 2.872

3.  Design and in vitro assessment of an improved, low-resistance compliant thoracic artificial lung.

Authors:  Rebecca E Schewe; Khalil M Khanafer; Aarthi Arab; Jeffrey A Mitchell; David J Skoog; Keith E Cook
Journal:  ASAIO J       Date:  2012 Nov-Dec       Impact factor: 2.872

4.  Hemodynamic design requirements for in-series thoracic artificial lung attachment in a model of pulmonary hypertension.

Authors:  Begum Akay; Julie A Foucher; Daniele Camboni; Kelly L Koch; Ayushi Kawatra; Keith E Cook
Journal:  ASAIO J       Date:  2012 Jul-Aug       Impact factor: 2.872

5.  In-parallel attachment of a low-resistance compliant thoracic artificial lung under rest and simulated exercise.

Authors:  Rebecca E Schewe; Christopher N Scipione; Kelly L Koch; Keith E Cook
Journal:  Ann Thorac Surg       Date:  2012-09-07       Impact factor: 4.330

6.  A Model of Pediatric End-Stage Lung Failure in Small Lambs <20 kg.

Authors:  Benjamin D Carr; Clinton J Poling; Pavel Hala; Matias Caceres Quinones; Aaron R Prater; Jennifer S McLeod; Robert H Bartlett; Alvaro Rojas-Pena; Ronald B Hirschl
Journal:  ASAIO J       Date:  2020-05       Impact factor: 3.826

7.  Interactive simulator for e-Learning environments: a teaching software for health care professionals.

Authors:  Claudio De Lazzari; Igino Genuini; Domenico M Pisanelli; Alessandra D'Ambrosi; Francesco Fedele
Journal:  Biomed Eng Online       Date:  2014-12-18       Impact factor: 2.819

8.  First in vivo assessment of RAS-Q technology as lung support device for pulmonary hypertension.

Authors:  Tom Verbelen; Michael Halwes; Bart Meyns
Journal:  Int J Artif Organs       Date:  2020-09-10       Impact factor: 1.595

Review 9.  Bioengineering Progress in Lung Assist Devices.

Authors:  Ahad Syed; Sarah Kerdi; Adnan Qamar
Journal:  Bioengineering (Basel)       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.